Ost-müük Anika - ANIK CFD
Lisa lemmikuks- Kokkuvõte
- Ajaloolised andmed
- Sündmused
- Tuluaruanne
- Bilanss
- Rahavood
- Omand
Hinnavahe | 0.11 | ||||||||
Pika positsiooni ööpäeva tasu
Long position overnight fee
Mine platvormile | -0.025457% | ||||||||
Lühikese positsiooni ööpäeva tasu
Short position overnight fee
Mine platvormile | 0.003235% | ||||||||
Ööpäeva tasu aeg | 21:00 (UTC) | ||||||||
Min kauplemise kogus | 1 | ||||||||
Valuuta | USD | ||||||||
Tagatis | 20% | ||||||||
Aktsiabörs | United States of America | ||||||||
Kauplemise vahendustasu | 0% |
*Information provided by Capital.com
Anika Therapeutics Inc ESG Risk Ratings
‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.
Eelmine sulgemine* | 22.16 |
Avatud* | 21.87 |
Aastane muutus* | -2.63% |
Päeva ulatus* | 21.87 - 22.64 |
52 nädala ulatus | 20.12-32.51 |
Keskmine maht (10 päeva) | 66.79K |
Keskmine maht (3 kuud) | 1.71M |
Turukapitalisatsioon | 399.77M |
P/E suhtarv | -100.00K |
Ringluses olevad aktsiad | 14.76M |
Tulu | 157.47M |
EPS | -1.52 |
Dividendid (% kasumist) | N/A |
Beeta | 0.84 |
Järgmine tuluaruande kuupäev | Aug 1, 2023 |
Kõigi andmete allikas on Refinitiv, välja arvatud tärniga märgitud, kus *-ga andmed on esitanud Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Sulgemishind | Change (%) | Avamishind | High | Low |
---|---|---|---|---|---|---|
Jun 29, 2022 | 22.44 | 0.97 | 4.52% | 21.47 | 22.76 | 21.47 |
Jun 28, 2022 | 22.16 | -0.44 | -1.95% | 22.60 | 22.94 | 22.05 |
Jun 27, 2022 | 22.89 | 0.66 | 2.97% | 22.23 | 23.15 | 22.15 |
Jun 24, 2022 | 22.45 | -0.06 | -0.27% | 22.51 | 23.69 | 22.15 |
Jun 23, 2022 | 23.46 | 0.91 | 4.04% | 22.55 | 23.48 | 22.53 |
Jun 22, 2022 | 22.53 | 0.56 | 2.55% | 21.97 | 22.73 | 21.97 |
Jun 21, 2022 | 22.35 | 0.60 | 2.76% | 21.75 | 22.98 | 21.75 |
Jun 17, 2022 | 22.01 | 0.00 | 0.00% | 22.01 | 22.64 | 21.81 |
Jun 16, 2022 | 21.97 | 0.87 | 4.12% | 21.10 | 22.05 | 21.08 |
Jun 15, 2022 | 21.93 | 1.48 | 7.24% | 20.45 | 21.97 | 20.40 |
Jun 14, 2022 | 20.43 | 0.22 | 1.09% | 20.21 | 20.53 | 20.06 |
Jun 13, 2022 | 20.41 | -0.09 | -0.44% | 20.50 | 20.61 | 19.97 |
Jun 10, 2022 | 21.00 | -0.62 | -2.87% | 21.62 | 21.68 | 20.87 |
Jun 9, 2022 | 21.91 | 0.32 | 1.48% | 21.59 | 22.12 | 21.58 |
Jun 8, 2022 | 21.95 | 0.17 | 0.78% | 21.78 | 22.10 | 21.29 |
Jun 7, 2022 | 21.96 | 0.19 | 0.87% | 21.77 | 22.08 | 21.72 |
Jun 6, 2022 | 21.92 | -0.04 | -0.18% | 21.96 | 22.55 | 21.74 |
Jun 3, 2022 | 22.24 | 0.69 | 3.20% | 21.55 | 22.33 | 21.37 |
Jun 2, 2022 | 21.94 | 0.55 | 2.57% | 21.39 | 22.06 | 21.39 |
Jun 1, 2022 | 21.68 | 0.57 | 2.70% | 21.11 | 22.03 | 21.11 |
Anika Events
Kellaaeg (UTC) (UTC) | Riik | Sündmus |
---|---|---|
Thursday, June 8, 2023 | ||
Kellaaeg (UTC) (UTC) 13:00 | Riik US
| Sündmus Anika Therapeutics Inc Annual Shareholders Meeting Anika Therapeutics Inc Annual Shareholders MeetingForecast -Previous - |
Wednesday, June 14, 2023 | ||
Kellaaeg (UTC) (UTC) 13:00 | Riik US
| Sündmus Anika Therapeutics Inc Annual Shareholders Meeting Anika Therapeutics Inc Annual Shareholders MeetingForecast -Previous - |
Tuesday, August 1, 2023 | ||
Kellaaeg (UTC) (UTC) 10:59 | Riik US
| Sündmus Q2 2023 Anika Therapeutics Inc Earnings Release Q2 2023 Anika Therapeutics Inc Earnings ReleaseForecast -Previous - |
Monday, November 6, 2023 | ||
Kellaaeg (UTC) (UTC) 21:00 | Riik US
| Sündmus Q3 2023 Anika Therapeutics Inc Earnings Release Q3 2023 Anika Therapeutics Inc Earnings ReleaseForecast -Previous - |
- Aastas
- Kvartalis
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Kogutulu | 156.236 | 147.794 | 130.457 | 114.61 | 105.555 |
Tulu | 156.236 | 147.794 | 130.457 | 114.61 | 105.555 |
Kulud, Kokku | 62.66 | 64.851 | 61.431 | 28.747 | 31.28 |
Brutokasum | 93.576 | 82.943 | 69.026 | 85.863 | 74.275 |
Kogu tegevuskulu | 175.636 | 145.179 | 158.779 | 80.362 | 83.806 |
Müük/Üldine/admin kulud, kokku | 84.794 | 74.096 | 60.063 | 34.95 | 34.336 |
Uuringud ja arendus | 28.182 | 27.327 | 23.431 | 16.665 | 18.19 |
Tulud majandustegevusest | -19.4 | 2.615 | -28.322 | 34.248 | 21.749 |
Intressitulud (kulu), muud tulud, neto | 0.654 | -0.188 | -0.302 | 1.873 | 1.458 |
Netotulu enne makse | -18.746 | 2.427 | -28.624 | 36.121 | 23.207 |
Netotulu pärast makse | -14.859 | 4.134 | -23.982 | 27.193 | 18.722 |
Netotulu enne erikulusid | -14.859 | 4.134 | -23.982 | 27.193 | 18.722 |
Netotulu | -14.859 | 4.134 | -23.982 | 27.193 | 18.722 |
Arvestatav tulu, v a erikulud | -14.859 | 4.134 | -23.982 | 27.193 | 18.722 |
Arvestatav tulu, koos erikuludega | -14.859 | 4.134 | -23.982 | 27.193 | 18.722 |
Jaotamisele kuuluv netotulu | -14.859 | 4.134 | -23.982 | 27.193 | 18.722 |
Keskmine jaotamisele kuuluv aktsia kohta | 14.561 | 14.634 | 14.222 | 14.374 | 14.689 |
Jaotatav EPS, v a erakorralised kulud | -1.02047 | 0.28249 | -1.68626 | 1.89182 | 1.27456 |
Jaotamisele kuuluv normaal-EPS | -1.02047 | 0.56965 | 0.25707 | 1.89182 | 1.27456 |
Erakorralised kulud kokku | 0 | ||||
Ootamatud kulutused (tulu) | 0 | 0 | 42.52 | ||
Other Operating Expenses, Total | 0 | -21.095 | -28.666 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Kogutulu | 37.924 | 39.622 | 40.264 | 39.657 | 36.693 |
Tulu | 37.924 | 39.622 | 40.264 | 39.657 | 36.693 |
Kulud, Kokku | 15.081 | 15.491 | 17.485 | 14.795 | 14.889 |
Brutokasum | 22.843 | 24.131 | 22.779 | 24.862 | 21.804 |
Kogu tegevuskulu | 50.477 | 46.289 | 46.062 | 43.038 | 40.247 |
Müük/Üldine/admin kulud, kokku | 22.915 | 23.049 | 21.276 | 21.268 | 19.201 |
Uuringud ja arendus | 8.4 | 7.749 | 7.301 | 6.975 | 6.157 |
Other Operating Expenses, Total | 0 | 0 | 0 | 0 | |
Tulud majandustegevusest | -12.553 | -6.667 | -5.798 | -3.381 | -3.554 |
Intressitulud (kulu), muud tulud, neto | 0.539 | 0.276 | 0.436 | 0.096 | -0.154 |
Netotulu enne makse | -12.014 | -6.391 | -5.362 | -3.285 | -3.708 |
Netotulu pärast makse | -10.35 | -4.908 | -4.175 | -2.843 | -2.933 |
Netotulu enne erikulusid | -10.35 | -4.908 | -4.175 | -2.843 | -2.933 |
Netotulu | -10.35 | -4.908 | -4.175 | -2.843 | -2.933 |
Arvestatav tulu, v a erikulud | -10.35 | -4.908 | -4.175 | -2.843 | -2.933 |
Arvestatav tulu, koos erikuludega | -10.35 | -4.908 | -4.175 | -2.843 | -2.933 |
Jaotamisele kuuluv netotulu | -10.35 | -4.908 | -4.175 | -2.843 | -2.933 |
Keskmine jaotamisele kuuluv aktsia kohta | 14.653 | 14.618 | 14.603 | 14.555 | 14.466 |
Jaotatav EPS, v a erakorralised kulud | -0.70634 | -0.33575 | -0.2859 | -0.19533 | -0.20275 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
Jaotamisele kuuluv normaal-EPS | -0.52531 | -0.33575 | -0.2859 | -0.19533 | -0.20275 |
Ootamatud kulutused (tulu) | 4.081 | 0 |
- Aastas
- Kvartalis
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Käibevarad kokku | 169.547 | 168.528 | 177.383 | 234.306 | 202.943 |
Raha ja lühiajalised investeeringud | 86.327 | 94.386 | 98.318 | 184.943 | 159.014 |
Raha ja ekvivalendid | 86.327 | 94.386 | 95.817 | 157.463 | 89.042 |
Lühiajalised investeeringud | 0 | 2.501 | 27.48 | 69.972 | |
Laekumata arved, neto | 34.627 | 29.843 | 24.102 | 23.079 | 20.775 |
Accounts Receivable - Trade, Net | 34.627 | 29.843 | 24.102 | 23.079 | 20.775 |
Total Inventory | 39.765 | 36.01 | 46.209 | 21.995 | 21.3 |
Prepaid Expenses | 8.828 | 8.289 | 8.754 | 4.289 | 1.854 |
Total Assets | 349.128 | 347.535 | 365.605 | 330.71 | 278.993 |
Property/Plant/Equipment, Total - Net | 78.975 | 68.559 | 73.232 | 73.647 | 54.111 |
Property/Plant/Equipment, Total - Gross | 125.158 | 108.142 | 107.919 | 102.157 | 78.181 |
Accumulated Depreciation, Total | -46.183 | -39.583 | -34.687 | -28.51 | -24.07 |
Goodwill, Net | 7.339 | 7.781 | 8.413 | 7.694 | 7.851 |
Intangibles, Net | 74.599 | 82.382 | 91.157 | 7.585 | 9.191 |
Other Long Term Assets, Total | 18.668 | 20.285 | 15.42 | 7.478 | 4.897 |
Total Current Liabilities | 27.914 | 29.795 | 36.867 | 16.277 | 11.289 |
Accounts Payable | 9.074 | 7.633 | 8.984 | 3.832 | 3.143 |
Accrued Expenses | 18.03 | 17.659 | 14.645 | 12.445 | 8.146 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities, Total | 0.81 | 4.315 | 13.09 | ||
Total Liabilities | 63.565 | 60.45 | 93.205 | 42.332 | 15.381 |
Total Long Term Debt | 0 | 0 | 0 | 0 | 0 |
Deferred Income Tax | 6.436 | 10.157 | 11.895 | 4.331 | 3.542 |
Other Liabilities, Total | 29.215 | 20.498 | 44.443 | 21.724 | 0.55 |
Total Equity | 285.563 | 287.085 | 272.4 | 288.378 | 263.612 |
Common Stock | 0.146 | 0.144 | 0.143 | 0.143 | 0.142 |
Additional Paid-In Capital | 81.141 | 67.081 | 55.355 | 48.707 | 50.763 |
Retained Earnings (Accumulated Deficit) | 210.719 | 225.578 | 221.444 | 245.426 | 218.233 |
Other Equity, Total | -6.443 | -5.718 | -4.542 | -5.898 | -5.526 |
Total Liabilities & Shareholders’ Equity | 349.128 | 347.535 | 365.605 | 330.71 | 278.993 |
Total Common Shares Outstanding | 14.625 | 14.441 | 14.329 | 14.308 | 14.21 |
Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 0 | 0.188 | 0.148 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Käibevarad kokku | 160.331 | 169.547 | 167.761 | 167.856 | 165.322 |
Raha ja lühiajalised investeeringud | 79.737 | 86.327 | 87.777 | 91.392 | 90.325 |
Raha ja ekvivalendid | 79.737 | 86.327 | 87.777 | 91.392 | 90.325 |
Lühiajalised investeeringud | |||||
Laekumata arved, neto | 30.629 | 34.627 | 34.168 | 32.172 | 29.313 |
Accounts Receivable - Trade, Net | 30.629 | 34.627 | 34.168 | 32.172 | 29.313 |
Total Inventory | 41.319 | 39.765 | 37.237 | 35.336 | 35.225 |
Prepaid Expenses | 8.646 | 8.828 | 8.579 | 8.956 | 10.459 |
Total Assets | 339.074 | 349.128 | 347.746 | 354.123 | 342.239 |
Property/Plant/Equipment, Total - Net | 78.978 | 78.975 | 78.377 | 79.694 | 68.471 |
Goodwill, Net | 7.462 | 7.339 | 6.721 | 7.169 | 7.625 |
Intangibles, Net | 72.653 | 74.599 | 76.545 | 78.49 | 80.436 |
Other Long Term Assets, Total | 19.65 | 18.668 | 18.342 | 20.914 | 20.385 |
Total Current Liabilities | 28.693 | 27.914 | 26.352 | 29.431 | 26.992 |
Accounts Payable | 8.948 | 9.074 | 8.353 | 8.165 | 7.444 |
Accrued Expenses | 18.856 | 18.03 | 17.999 | 16.819 | 15.111 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 0 | 0 | 0.132 | 0.122 | |
Other Current Liabilities, Total | 0.889 | 0.81 | 0 | 4.315 | 4.315 |
Total Liabilities | 61.486 | 63.565 | 62.809 | 67.97 | 56.452 |
Total Long Term Debt | 0 | 0 | 0 | 0 | 0 |
Deferred Income Tax | 4.114 | 6.436 | 6.8 | 8.22 | 9.956 |
Other Liabilities, Total | 28.679 | 29.215 | 29.657 | 30.319 | 19.504 |
Total Equity | 277.588 | 285.563 | 284.937 | 286.153 | 285.787 |
Common Stock | 0.147 | 0.146 | 0.146 | 0.146 | 0.145 |
Additional Paid-In Capital | 83.243 | 81.141 | 76.661 | 72.851 | 68.796 |
Retained Earnings (Accumulated Deficit) | 200.369 | 210.719 | 215.627 | 219.802 | 222.645 |
Other Equity, Total | -6.171 | -6.443 | -7.497 | -6.646 | -5.799 |
Total Liabilities & Shareholders’ Equity | 339.074 | 349.128 | 347.746 | 354.123 | 342.239 |
Total Common Shares Outstanding | 14.741 | 14.625 | 14.607 | 14.598 | 14.518 |
Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 |
- Aastas
- Kvartalis
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Netotulu/algväärtus | -14.859 | 4.134 | -23.982 | 27.193 | 18.722 |
Raha majandustegevusest | 4.409 | 8.397 | 13.065 | 37.005 | 34.918 |
Raha majandustegevusest | 6.704 | 6.48 | 13.464 | 5.991 | 5.91 |
Deferred Taxes | -5.27 | -1.766 | -3.543 | 0.794 | -1.817 |
Mittelikviidsed varad | 21.872 | 3.65 | 40.062 | 9.67 | 15.303 |
Cash Taxes Paid | 0.106 | 1.233 | 0.993 | 9.257 | 5.56 |
Muutused tööjõus | -11.821 | -11.938 | -12.936 | -6.643 | -3.2 |
Tulu investeeringutelt | -7.486 | -3.118 | -71.264 | 39.691 | -50.257 |
Kapitalikulutused | -7.486 | -5.143 | -1.628 | -2.827 | -4.656 |
Muud rahavood investeeringutelt, kokku | 0 | 2.025 | -69.636 | 42.518 | -45.601 |
Rahavood investeeringutelt | -4.852 | -6.779 | -3.774 | -8.142 | -28.904 |
Aktsiate emiteerimine (tagasiost), neto | 0.016 | 1.128 | 1.524 | -7.849 | -27.114 |
Laenu väljastamine (kustutamine), neto | -0.284 | -0.201 | -0.558 | ||
Muutused valuutakursside kõikumisest | -0.13 | 0.069 | 0.327 | -0.133 | 0.029 |
Rahaline kogumuutus | -8.059 | -1.431 | -61.646 | 68.421 | -44.214 |
Rahavoogudesse investeerimine | -4.584 | -7.706 | -4.74 | -0.293 | -1.79 |
Amortization | 7.783 | 7.837 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -10.35 | -14.859 | -9.951 | -5.776 | -2.933 |
Cash From Operating Activities | -3.618 | 4.409 | 3.928 | 1.219 | -1.869 |
Cash From Operating Activities | 1.605 | 6.704 | 4.984 | 3.435 | 1.671 |
Deferred Taxes | -2.373 | -5.27 | -3.491 | -2.02 | -0.273 |
Non-Cash Items | 4.912 | 21.872 | 15.904 | 8.273 | 3.539 |
Cash Taxes Paid | |||||
Changes in Working Capital | 0.642 | -11.821 | -9.355 | -6.584 | -5.819 |
Cash From Investing Activities | -1.389 | -7.486 | -4.957 | -3.266 | -1.326 |
Capital Expenditures | -1.389 | -7.486 | -4.957 | -3.266 | -1.326 |
Other Investing Cash Flow Items, Total | 0 | 0 | 0 | 0 | |
Cash From Financing Activities | -1.613 | -4.852 | -5.519 | -0.908 | -0.862 |
Financing Cash Flow Items | -1.62 | -4.584 | -5.25 | -0.87 | -0.846 |
Issuance (Retirement) of Debt, Net | 0 | -0.284 | -0.284 | -0.053 | -0.031 |
Foreign Exchange Effects | 0.03 | -0.13 | -0.061 | -0.039 | -0.004 |
Net Change in Cash | -6.59 | -8.059 | -6.609 | -2.994 | -4.061 |
Issuance (Retirement) of Stock, Net | 0.007 | 0.016 | 0.015 | 0.015 | 0.015 |
Amortization | 1.946 | 7.783 | 5.837 | 3.891 | 1.946 |
Investori nimi | Investori liik | Ringluse protsent | Hoitud osakud | Muutus osakutes | Hoidmise kuupäev | Hinnang käibele |
---|---|---|---|---|---|---|
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 15.2223 | 2246378 | -61344 | 2023-03-31 | LOW |
Trigran Investments, Inc. | Hedge Fund | 10.8328 | 1598614 | 34073 | 2023-03-31 | LOW |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 6.6442 | 980496 | -1565 | 2023-03-31 | LOW |
Dimensional Fund Advisors, L.P. | Investment Advisor/Hedge Fund | 6.6293 | 978300 | 18554 | 2023-03-31 | LOW |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 6.2328 | 919788 | 10921 | 2023-03-31 | LOW |
Caligan Partners, LP | Hedge Fund | 4.8471 | 715291 | 123616 | 2023-03-31 | MED |
Janus Henderson Investors | Investment Advisor/Hedge Fund | 4.6223 | 682124 | 68418 | 2023-03-31 | LOW |
Renaissance Technologies LLC | Hedge Fund | 3.8992 | 575417 | -20112 | 2023-03-31 | HIGH |
Boothbay Fund Management, LLC | Investment Advisor/Hedge Fund | 3.3001 | 486997 | 119487 | 2023-03-31 | HIGH |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 1.929 | 284665 | 9043 | 2023-03-31 | LOW |
Portolan Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 1.4574 | 215075 | 7175 | 2023-03-31 | HIGH |
Acadian Asset Management LLC | Investment Advisor/Hedge Fund | 1.1733 | 173146 | 16879 | 2023-03-31 | MED |
Columbia Threadneedle Investments (US) | Investment Advisor/Hedge Fund | 1.1124 | 164165 | 24284 | 2023-03-31 | LOW |
Blanchard (Cheryl R) | Individual Investor | 1.0203 | 150572 | 38968 | 2023-04-26 | LOW |
D. E. Shaw & Co., L.P. | Hedge Fund | 0.9369 | 138267 | -7359 | 2023-03-31 | LOW |
Northern Trust Investments, Inc. | Investment Advisor/Hedge Fund | 0.9214 | 135972 | -1407 | 2023-03-31 | LOW |
Fisher Investments | Investment Advisor/Hedge Fund | 0.905 | 133547 | 534 | 2023-03-31 | LOW |
Franklin Mutual Advisers, LLC | Investment Advisor/Hedge Fund | 0.8402 | 123992 | 15600 | 2023-03-31 | MED |
Two Sigma Investments, LP | Hedge Fund | 0.826 | 121888 | -27027 | 2023-03-31 | HIGH |
Nuveen LLC | Pension Fund | 0.8214 | 121212 | 51420 | 2023-03-31 | LOW |
Miks valida Capital.com? Meie numbrid räägivad iseenda eest.
Capital.com Group535K+
Kauplejad
87K+
Igakuiste aktiivsete klientide arv
$113M+
Igakuine investeerimise maht
$64M+
Igakuiselt välja võetud
Kauplemiskalkulaator
Arvutage oma hüpoteetiline võit/kaotus, kui oleksite avanud CFD-tehingu ühel kindlal kuupäeval (valige kuupäev) ja sulgenud teisel kuupäeval (valige kuupäev).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Anika Company profile
Ettevõttest Anika
Anika Therapeutics, Inc. on ühine säilitamisettevõte. Ettevõte loob ja pakub uuendusi varajase sekkumise ortopeedilises hoolduses, sealhulgas osteoartriidi (OA) valuravi, regeneratiivsete lahenduste, pehmete kudede taastamise ja luude säilitamise tehnoloogiate valdkonnas. Ettevõte keskendub oma hüaluroonhappe (HA) tehnoloogiaplatvormil põhinevate toodete arendamisele, tootmisele ja turustamisele. Tema tootekategooriate hulka kuuluvad liigesevalu ravimeetodid, liigeste säilitamine ja taastamine ning muud. Liigesevalu ravimeetodid pakuvad süstitavaid viskooslisandeid, mis leevendavad valu osteoartriidi korral, ning selle toodete hulka kuuluvad MONOVISC, ORTHOVISC, CINGAL ja HYVISC. Liigeste säilitamise ja taastamise hooldustoodete hulka kuuluvad HYALOFAST ja TACTOSET. Muude toodete hulka kuuluvad Hyalobarrier ja Hyaloglide.
Industry: | Biopharmaceuticals |
32 Wiggins Ave
BEDFORD
MASSACHUSETTS 01730-2315
US
Tuluaruanne
- Annual
- Quarterly
Teised on vaadanud veel
Kas otsite jätkuvalt vahendajat, keda saab usaldada?
Ühinege 535,000+ kauplejaga üle kogu maailma, kes valisid kauplemiseks veebisaidi Capital.com